Medipost Inc. Submits Ind Amendment With U.S. Food And Drug Administration To Initiate Phase Iii Trial

About this update from Medipost Co., Ltd.

Medipost Co Ltd KRX:078160:MEDIPOST INC. SUBMITS IND AMENDMENT WITH U.S. FOOD AND DRUG ADMINISTRATION TO INITIATE PHASE III TRIALMEDIPOST:IND AMENDMENT SUBMITTED TO FDA TO SUPPORT INITIATING PHASE III CLINICAL TRIAL EVALUATING INVESTIGATIONAL CELL THERAPY FOR KNEE OSTEOARTHRITIS

View stock analysis, news, and events for Medipost Co., Ltd.